** Shares of Microba Life Sciences MAP.AX fall 17.8% to A$0.185
** Stock set for its weakest session since October 23, 2023- if current trends hold
** Health sciences co posts a 15% decline in Q3 revenue compared to last year
** But, co sees FY25 revenue to be up 26%-34% from last year
** Co set for its strongest month since January
** About 559,491 shares change hands, 3.7x the 30-day average of 152,712 shares
** Stock down 5.1% YTD, including current session's moves
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。